NAMS icon

NewAmsterdam Pharma
NAMS

Overview Fund Activity

76 hedge funds and large institutions have $1.71B invested in NewAmsterdam Pharma in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+44
Holders Change %
+137.5%
% of All Funds
1.1%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
46
Increased
13
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$35.5M
2
PCH
2
Polar Capital Holdings
United Kingdom
$29.6M
3
Jennison Associates
3
Jennison Associates
New York
$22M
4
AG
4
Artal Group
Luxembourg
$18.9M
5
DM
5
Deerfield Management
New York
$15.8M

Top Sellers

1
GC
1
GMT Capital
Georgia
$22.3M
2
Millennium Management
2
Millennium Management
New York
$22.4M
3
Goldman Sachs
3
Goldman Sachs
New York
$30.4M
4
PHP
4
Parkman Healthcare Partners
Connecticut
$4.74M
5
Axa
5
Axa
France
$5.89M
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
76
Dupont Capital Management
Delaware
$24 – – –
CG
77
Cutler Group
California
– -$5K -500 Closed
AWM
78
Atticus Wealth Management
Florida
– -$1.12K -100 Closed
1 2 3
4